non-canonical-peptides-mopepgen-nature-biotechnology The traditional view of adaptive immunity centers on the presentation of peptide fragments by Major Histocompatibility Complex (MHC) molecules to T cells. However, a growing body of research reveals that the immune system also recognizes and responds to non-peptide antigens, a diverse class of molecules that are presented through distinct pathways. This expanded understanding of antigen presentation is crucial for comprehending host defense against infections, autoimmunity, and even tumor immunosurveillance. While peptides are the most common antigens, the ability of T cells to recognize non-peptidic forms highlights the sophisticated and multifaceted nature of immune recognition.
Unlike peptides, which are derived from protein degradation, non-peptide antigens encompass a broad spectrum of molecules. These include lipids, glycolipids, metabolites, and even certain drugs. The recognition of these diverse structures by T cells is mediated by specialized antigen-presenting molecules, distinct from the classical MHC class I and II pathwaysNon-peptidicantigens are low-molecular-weight compounds that stimulate human Vγ9/Vδ2 T cells. The most potent activator for Vγ9/Vδ2 T cells is (E)-4-hydroxy-3 ....
Key non-peptide antigen presenters include:
* CD1 proteins: This family of MHC-like molecules, particularly CD1b and CD1d, are specialized in presenting lipid and glycolipid antigens. These are often derived from microbial pathogens, such as mycobacteria, and are critical for initiating immune responses against such infections.
* MR1 (MHC Class I-Related Molecule 1): MR1 presents small molecules derived from microbial metabolic pathways, such as vitamin B metabolites.Antigen processing and presentation ... Its recognition is primarily by a subset of T cells known as Mucosal-Associated Invariant T (MAIT) cells, which play a significant role in early responses to bacterial and fungal infections.
* Butyrophilin 3A1 (BTN3A1): This molecule has emerged as a key presenter of non-peptide antigens, particularly those involved in the activation of $\gamma\delta$ T cells.
The presentation of non-peptide antigens involves distinct cellular processes compared to peptide presentation. Instead of intracellular proteolysis and loading onto MHC molecules in the endoplasmic reticulum, these antigens are often processed and trafficked through different cellular compartments.
For instance, lipid antigens presented by CD1 molecules can be derived from extracellular sources or synthesized within cellsAntigen Processing and Presentation. Their association with CD1 proteins and subsequent transport to the cell surface for T cell recognition involves specific lipid-binding grooves and accessory proteins. Similarly, MR1 presents its cognate ligands to MAIT cells, triggering rapid cytokine production and immune cell activationThe usual process ofantigen presentationthrough the MHC I molecule is based on an interaction between the T-cell receptor and a peptide bound to the MHC class I molecule. There is also an interaction between the CD8+ molecule on the surface of the T cell andnon-peptidebinding regions on the MHC class I molecule..
The ability of T cells to recognize non-peptide antigens has profound implications for various immunological contexts:
* Infectious Diseases: The immune response to many microbial pathogens relies heavily on the presentation of non-peptide antigens.Non-peptidic antigen For example, the potent activation of $\gamma\delta$ T cells by (E)-4-hydroxy-3-methyl-2-butenyl pyrophosphate (HMB-PP), a non-peptide molecule produced by bacteria and plants, is crucial for early defenseAntigen Processing and Presentation.
* Autoimmunity: Aberrant recognition of self-derived non-peptide molecules by T cells can contribute to autoimmune diseases. Understanding these pathways is vital for developing targeted immunotherapies.
* Drug Hypersensitivity: Certain drugs can act as non-peptide antigens, triggering T cell-mediated allergic or toxic reactions. The presentation of these small molecular compounds by specific T cells is an area of ongoing research.
* Tumor Immunosurveillance: While less studied than peptide antigens, non-peptide antigens derived from tumor cells or the tumor microenvironment may also contribute to anti-tumor immunity.
The fundamental difference lies in the nature of the antigen itself: peptides are amino acid chains, while non-peptide antigens are chemically diverse, including lipids, small organic molecules, and metabolites. This chemical disparity necessitates different antigen-presenting molecules and cellular machinery.Professional antigen presenting cells (APC) and MHC II complexes (video) While MHC molecules are highly polymorphic and present a vast array of peptides, CD1 and MR1 molecules are generally non-polymorphic, suggesting they present conserved ligands important for recognizing broad categories of pathogens or endogenous molecules.
Continued research into non-peptide antigen presentation is essential for a comprehensive understanding of the immune system. Developing novel assays for measuring non-peptide antigen presentation and identifying new non-peptide antigens will pave the way for improved diagnostics and therapeutics for a range of immune-related disorders. The exploration of non-enzymatic post-translational modifications (PTMs) on antigen presentation also adds another layer of complexity to this field, hinting at further intricate mechanisms of immune recognition.
Join the newsletter to receive news, updates, new products and freebies in your inbox.